Molecular Partners AG: INVITATION: Friday, June 26, 2020, 8:00am (CET) – Conference Call for Analysts and Institutional Investors Freitag, 26. Juni 2020 - 07:25
Molecular Partners AG cordially invites financial analysts and institutional investors to participate in the conference call regarding the following media release issued:
"Allergan, an AbbVie Company, and Molecular Partners Receive Complete Response Letter from FDA on Biologics License Application for Abicipar pegol"
Date & Time:
Friday, June 26, 2020
8:00am CET (7:00am GMT, 2:00am EST)
Dial-ins conference call:
Switzerland / Europe +41 58 310 5000
UK +44 207 107 0613
US +1 631 570 5613
Please dial-in approximately 10 minutes before the start of the presentation in order to register. Participants will have the opportunity to ask questions after the presentation.
For further details, please contact:
Seth Lewis, SVP IR, Comms, & Strategy |
| Tom Donovan, U.S. Media |
| ||
Tel: +1 781 420 2361 |
| Tel: +1 857 559 3397 |
|
|
|
Thomas Schneckenburger, IR & European Media |
| |
| ||
Tel: +41 79 4079952 |
|
This communication does not constitute an offer or invitation to subscribe for or purchase any securities of Molecular Partners AG. This publication may contain certain forward-looking statements and assessments or intentions concerning the company and its business. Such statements involve certain risks, uncertainties and other factors which could cause the actual results, financial condition, performance or achievements of the company to be materially different from those expressed or implied by such statements. Readers should therefore not place reliance on these statements, particularly not in connection with any contract or investment decision. The company disclaims any obligation to update these forward-looking statements, assessments or intentions.